Uncategorized

WEDNESDAY, Nov. 13, 2019 (HealthDay News) — Melanoma incidence seems to be decreasing in adolescents and young adults, according to a study published online Nov. 13 in JAMA Dermatology. Kelly G. Paulson, M.D., Ph.D., from...

SAN FRANCISCO – New research from Taiwan shows that severe sleep apnea is a risk factor for developing diabetic macular edema, a complication of diabetes that can cause vision loss or blindness. Diabetic macular edema was also...

Compared with placebo, anifrolumab was found to demonstrate robust efficacy in patients with moderate to severe systemic lupus erythematosus (SLE), according to research presented at the 2019 American College of...

CDC, the Food and Drug Administration (FDA), state and local health departments, and multiple public health and clinical partners are investigating a national outbreak of e-cigarette, or vaping, product use–associated lung...

The following press release was published by the American Academy of Pediatrics:  ROSEMONT, Ill. (Oct. 29, 2019) — Board-certified dermatologists are experts when it comes to the skin, hair and nails, diagnosing and treating...

The following press release was published by the American Academy of Pediatrics: ROSEMONT, Ill. (Nov. 5, 2019) — One-third of psoriasis cases begin in the pediatric years, and onset is most common during adolescence for the...

The following press release was published by Sanofi:  The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for use in...

THURSDAY, Oct. 31, 2019 (HealthDay News) — For relapsed or refractory acute myeloid leukemia (AML) with mutations in the FMS-like tyrosine kinase 3 gene (FLT3), treatment with a selective FLT3 inhibitor, gilteritinib,...